| Schedule of Significant Segment Expenses |
esearch and development and general and administrative expenses are significant segment expenses regularly provided to the CODM with the following categories:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
|
|
|
|
|
|
|
Significant Segment Expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Personnel related costs |
|
$ |
1,932 |
|
|
|
3,980 |
|
|
$ |
4,143 |
|
|
|
8,667 |
|
Clinical trial expenses |
|
|
1,482 |
|
|
|
1,240 |
|
|
|
2,480 |
|
|
|
2,364 |
|
Facilities expense |
|
|
1,380 |
|
|
|
1,633 |
|
|
|
2,904 |
|
|
|
3,469 |
|
Other research and development expenses |
|
|
793 |
|
|
|
1,357 |
|
|
|
1,517 |
|
|
|
4,173 |
|
Other general and administrative expenses |
|
|
1,261 |
|
|
|
1,831 |
|
|
|
2,683 |
|
|
|
3,597 |
|
Stock-based compensation expense |
|
|
552 |
|
|
|
625 |
|
|
|
1,097 |
|
|
|
1,334 |
|
Other segment expenses (1) |
|
|
171 |
|
|
|
348 |
|
|
|
374 |
|
|
|
747 |
|
Total significant segment expenses |
|
|
7,571 |
|
|
|
11,014 |
|
|
|
15,198 |
|
|
|
24,351 |
|
Impairment charges |
|
|
808 |
|
|
|
— |
|
|
|
808 |
|
|
|
— |
|
Total operating expenses |
|
|
8,379 |
|
|
|
11,014 |
|
|
|
16,006 |
|
|
|
24,351 |
|
_______________ (1) Other segment expense include depreciation expense and other miscellaneous expenses.
|